ERASCA INC(NASDAQ:ERAS) stock News

ERAS Latest News, Press Relases and Analysis

All

Press Releases

21 days ago - By: The Motley Fool

Erasca Narrows Loss 46% in Fiscal Q2

21 days ago - By: Erasca, Inc.

Erasca Reports Second Quarter 2025 Business Updates and Financial Results

3 months ago - By: Erasca, Inc.

Erasca to Present at Upcoming Investor Conferences in June

a year ago - By: BusinessInsider

ERAS Stock Earnings: Erasca Misses EPS for Q2 2024

a year ago - By: InvestorPlace

ERAS Stock Earnings: Erasca Misses EPS for Q2 2024

4 months ago - By: Erasca, Inc.

Erasca Reports First Quarter 2025 Business Updates and Financial Results

4 months ago - By: Erasca, Inc.

Erasca to Present at the Bank of America Securities Health Care Conference

4 months ago - By: Erasca, Inc.

Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting

4 months ago - By: Benzinga - Mentions: BTG WWW PCRX BEAM ...

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday

5 months ago - By: Yahoo Finance - Mentions: PLTR AAPL USB

Is Erasca Inc. (NASDAQ:ERAS) the Best Biotech Penny Stock to Buy According to Hedge Funds?

a year ago - By: InvestorPlace

ERAS Stock Earnings: Erasca Misses EPS for Q1 2024

5 months ago - By: Yahoo Finance - Mentions: MPC PTLO AMD NVDA ...

Should You Consider Adding Marathon Petroleum Corporation (MPC) to Your Portfolio?

5 months ago - By: Yahoo Finance - Mentions: GERN GOSS CAN GILD ...

Is Geron Corp. (NASDAQ:GERN) the Best Biotech Penny Stock to Buy According to Hedge Funds?

5 months ago - By: Benzinga - Mentions: THC SHAK SPOT SNEX

This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

5 months ago - By: Erasca, Inc.

Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting

6 months ago - By: Erasca, Inc.

Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results

7 months ago - By: Erasca, Inc.

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference

10 months ago - By: Erasca, Inc.

Erasca Reports Third Quarter 2024 Business Updates and Financial Results

10 months ago - By: Erasca, Inc.

Erasca to Present at Upcoming Investor Conferences

10 months ago - By: Erasca, Inc.

Erasca Announces Strong Momentum for Naporafenib and RAS Targeting Franchise

a year ago - By: Erasca, Inc.

Erasca to Present Preliminary SEACRAFT-1 Phase 1 Data for Naporafenib Plus Trametinib in RAS Q61X Mutant Solid Tumors as Oral Presentation at 36th EORTC-NCI-AACR Symposium

a year ago - By: Erasca, Inc.

Erasca Reports Second Quarter 2024 Business Updates and Financial Results

a year ago - By: Erasca, Inc.

Erasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

a year ago - By: Erasca, Inc.

Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise

a year ago - By: Erasca, Inc.

Erasca Announces Pricing of Underwritten Offering of Common Stock

a year ago - By: BusinessInsider

ERAS Stock Earnings: Erasca Misses EPS for Q1 2024

a year ago - By: Erasca, Inc.

Erasca Reports First Quarter 2024 Business Updates and Financial Results

a year ago - By: Erasca, Inc.

ERASCA INC (ERAS) Stock News

ERAS Latest News, Press Relases and Analysis